Tech Company Financing Transactions
Bambusa Therapeutics Funding Round
On 2/14/2025, Bambusa Therapeutics received $90 million in Series A funding from RA Capital Management, Invus and Janus Henderson Investors.
Transaction Overview
Company Name
Announced On
2/14/2025
Transaction Type
Venture Equity
Amount
$90,000,000
Round
Series A
Investors
Proceeds Purpose
The funding will support the advancement of Bambusa's lead programs through Phase I trials and drive further pipeline development.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
Boston, MA Undisclosed
USA
Boston, MA Undisclosed
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Bambusa Therapeutics is a rapidly growing biotechnology company specializing in developing transformative inflammatory and immunological therapeutics. Based in the vibrant Boston Seaport area, our mission is to advance the field of immunology with cutting-edge solutions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shanshan Xu
Co-Founder
Helmut Jeggle
Browse more venture capital transactions:
Prev: 2/14/2025: Antithesis venture capital transaction
Next: 2/14/2025: Surus venture capital transaction
Share this article
Where The Data Comes From
We document tech company VC transactions. VC transactions on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs